Baird Medical Investment Holdings (BDMD) Liabilities and Shareholders Equity (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $69.7 million in Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity fell 10.6% year-over-year to $69.7 million in Q4 2025; TTM through Dec 2025 was $281.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $69.7 million, down 10.6% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $69.7 million, down from $77.0 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for BDMD reached as high as $78.0 million in Q4 2024 and fell as low as $56.7 million in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $70.3 million across 3 years, with a median of $73.3 million in 2025.
• Across the five-year window, Liabilities and Shareholders Equity surged 37.48% in 2024 and decreased 10.6% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $56.7 million in 2023, then surged by 37.48% to $78.0 million in 2024, then decreased by 10.6% to $69.7 million in 2025.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $69.7 million in Q4 2025, $77.0 million in Q2 2025, and $78.0 million in Q4 2024.